|
2018
|
Invention
|
Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate.
Improv... |
|
|
Invention
|
Gaba analog prodrug sustained release oral dosage forms.
Sustained release oral dosage forms of ... |
|
|
Invention
|
Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. The disclosures herein relate gene... |
|
2017
|
Invention
|
Crystalline forms of (n, n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of sy... |
|
|
Invention
|
Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of syn... |
|
|
Invention
|
Crystalline form of y-aminobutyric acid analog.
A crystalline form of a γ-aminobutyric acid anal... |
|
2016
|
Invention
|
Gaba analog prodrug sustained release oral dosage forms. Sustained release oral dosage forms of a... |
|
|
Invention
|
Oral dosage forms having a high loading of a gabapentin prodrug.
Sustained release oral dosage f... |
|
|
Invention
|
Methods of use for monomethyl fumarate and prodrugs thereof. Methods of therapeutic treatment of ... |
|
|
Invention
|
Methods of synthesizing a levodopa ester prodrug. Methods of synthesizing a levodopa ester prodru... |
|
|
Invention
|
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof. Improved oral dosage forms of... |
|
2015
|
Invention
|
Prodrugs of gaba analogs, compositions and uses thereof.
The present invention provides prodrugs... |
|
|
Invention
|
Fumarate compounds, pharmaceutical compositions, and methods of use. Monomethyl and monoethyl fum... |
|
|
Invention
|
R)-baclofen prodrug, methods of synthesis and methods of use. Crystalline (3R)-4-{[(1S)-2-methyl-... |
|
|
Invention
|
Prodrugs of gaba analogs, compositions and uses thereof. The present invention provides prodrugs ... |
|
|
Invention
|
Pharmaceutical compositions of fumaric acid esters. Pharmaceutical compositions and dosage forms ... |
|
|
Invention
|
Methods of administering monomethyl fumarate.
Methods of therapeutic treatment using monomethyl ... |
|
2014
|
Invention
|
Nanoparticle compositions of dimethyl fumarate. Disclosed herein are compositions of dimethyl fum... |
|
|
Invention
|
Nanoparticle compositions of dimethyl fumarate.
Disclosed herein are compositions of dimethyl fu... |
|
|
Invention
|
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects.
M... |
|
|
Invention
|
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects. Me... |
|
|
Invention
|
Cocrystals of dimethyl fumarate. Disclosed herein are cocrystals of dimethyl fumarate, which is a... |
|
|
Invention
|
Cocrystals of dimethyl fumarate. Disclosed herein are cocrystals of dimethyl fumarate and gentisi... |
|
|
Invention
|
Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof. Pr... |
|
|
Invention
|
Method of making monomethyl fumarate. Methods of making monomethyl fumarate, which can then also ... |
|
|
Invention
|
Pharmaceutical compositions of dimethyl fumarate. Pharmaceutical compositions and dosage forms of... |
|
|
Invention
|
Crystalline form of γ-aminobutyric acid analog. A crystalline form of a γ-aminobutyric acid analo... |
|
|
Invention
|
Method of making 1-(acyloxy)-alkyl carbamate compounds.
Methods of preparing carbamate prodrugs ... |
|
|
Invention
|
Method of making 1-(acyloxy)-alkyl carbamate compounds. Methods of preparing carbamate prodrugs o... |
|
2013
|
Invention
|
Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate.
Disclosed herein are... |
|
|
Invention
|
Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate. Disclosed herein are ... |
|
|
Invention
|
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof.
Improved oral dosage forms o... |
|
|
Invention
|
Methods of administering monomethyl fumarate. Methods of therapeutic treatment using monomethyl f... |
|
|
Invention
|
Methods of use for monomethyl fumarate and prodrugs thereof.
Methods of therapeutic treatment us... |
|
2002
|
G/S
|
Biochemicals; transporter proteins; transporter proteins for pharmaceutical research and developm... |
|
2001
|
G/S
|
pharmaceutical drug research, development and testing services; consulting services in the pharma... |
